BioPortfolio Limited Hematological malignancies - Targeted treatments and immunotherapy infuse new blood TABLE OF CONTENTS ABOUT DATAMONITOR HEALTHCARE 2 About the Oncology pharmaceutical analysis team 2 CHAPTER 1 XECUTIVE SUMMARY 3 Datamonitor insight into the hematological malignancy market 3 R&D pipeline dynamics 3 Cytotoxic drugs – first-line indication for MGI Pharma/Supergen’s Dacogen ...
Database D D - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.Dacogen ™ (Decitabine, DAC) (1802) Dalbavancin...
August 31, 2003 page 10
August 31, 2003 SuperGen Decitabine; Cytosine analog that inhibits Phase III (begin 3/ 01, ongoing Pharmachemie dezocitidine NSC- DNA- methyltransferases, resulting 6/ 03) USA, phase III (begin 5/ 02, 127716, DAC Dacogen in gene demethylation and ongoing 6/ 03) Europe (The reactivation infusion Netherlands, Germany) advanced, high- risk MDS TAP Pharmaceutical Carbamic acid Antiangiogenic...
Pharmaceutical Research and Manufacturers of America - SuperGen Complete a new search Drug Name (Proprietary name/Generic name) Indications Addressed Click on indication to see all drugs for that indication Company Click a company to see all drugs for that company Development Status Notes Dacogen none / Decitabine Leukemia SuperGen Dublin, CA Phase I NCI Trial - Nipent¨ Nipent¨ / pentostatin Graft v
Pharmaceutical Research and Manufacturers of America - Leukemia Complete a new search Drug Name (Proprietary name/Generic name) Indications Addressed Click on indication to see all drugs for that indication Company Click a company to see all drugs for that company Development Status Notes none / bryostatin 1 Kidney Cancer Leukemia Lymphoma Ovarian Cancer Pancreatic Cancer Prostate Cancer Stomach Cancer National Cancer Institute...
Making a Real Difference in the Lives of Patients : MGI PHARMA Company History Executive Team Board of Directors Strategic Alliances In Our Community Awards MGI PHARMA Biologics Aloxi® Injection Gliadel® Wafer Hexalen® Capsules Salagen® Tablets Patient Stories Dacogen™ Injection Saforis™ Oral Suspension Aquavan® Injection Aloxi® Injection (PONV) Aloxi® Oral Formulation ZYC101a GPI 1485 Irofulven MG98...
BioPortfolio Limited Datamonitor Cardiovascular Reports [ Home ] - [ Up ] - [ Catalog ] - [ Info ] - [ Search ] - [ View Basket ] - [ Checkout ] - [ Send email ] - BioPortfolio accept VISA, MASTERCARD and AMEX Bioportfolio - - Datamonitor Cardiovascular Reports Heart Failure - Pumping Up Therapy Will Prevent Failure During the past two decades, heart failure has emerged as a major chronic disease among the elderly population in the major...
2004 Q4 Press Release.xls page 2
2004 Q4 Press Release.xls page 1
http://www.biotechnav.com/1-04NewsColorBlank.pdf 1 The investment report that gives you the essentials to wisely invest in biotechnology securitiesDacogen (decitabine) appear the closest to marketDacogen, so we cannot comment on interest in this agent
http://www.biotechnav.com/1-04NewsColorBlank.pdf page 4
http://www.phrma.org/newmedicines/resources/2003-05-12.109.pdf Triangle Park, NC vaccine) ABX- EGF Abgenix non- small- cell lung cancer (NSCLC) Phase II Fremont, CA (see also colon, kidney, prostate) (805) 447- 1000 Amgen Thousand Oaks, CA adenoviral p53 National Cancer Institute NSCLC Phase I Bethesda, MD N C I TR I A L (800) 422- 6237 Advexin ® Introgen Therapeutics (see also bladder, brain, breast, Phase II (adenoviral p53) Austin, TX...
http://www.phrma.org/newmedicines/resources/2003-05-12.109.pdf page 40
http://www.phrma.org/newmedicines/resources/2003-05-12.109.pdf page 19
http://www.phrma.org/newmedicines/resources/2003-05-12.109.pdf page 14
